Tag: postmenopausal hormone replacement therapy

FDA Approves First Once-Weekly Growth Hormone for Children

The US Food and Drug Administration (FDA) has approved lonapegsomatropin (Skytrofa, Ascendis Pharma), the first weekly subcutaneous injectable growth hormone for children with growth hormone...

Hormone Pellet Safety Data ‘Not Very Reassuring at All’ for Women

Women who receive pellet hormonal therapy may be significantly more likely to have side effects such as mood swings, anxiety, breast tenderness, hair pattern change,...

Transgender Resident Speaks Up on Coming Out in Medicine

Evelyn Carroll, MD, had planned on coming out as a transgender woman to her colleagues at the Mayo Clinic for the better part of a...

Increased Risk of Meningioma With Cyproterone Acetate Use

New details confirm an increased risk of developing intracranial meningiomas after prolonged use of the hormonal product cyproterone acetate. Cyproterone acetate is a synthetic progestogen...

Two-Stage Surgery to Reduce Ovarian Cancer Risk Piques Interest

“Many physicians would assume that prevention of cancer, especially cancer as serious as ovarian cancer, trumps all other decision making, but when we really listen...

HRT Update Regarding Breast Cancer Risk Advised in EU

In concluding their review of hormone replacement therapy (HRT) and the associated risk of breast cancer, the EU Pharmacovigilance Risk Assessment Committee (PRAC) has recommended...